The genes cyt1Aa and p20, encoding, respectively, cytolytic and accessory proteins of Bacillus thuringiensis subsp. israelensis, were introduced into previously constructed clones expressing cry4Aa and cry11Aa in Escherichia coli (Ben-Dov et al., 1995) . Fifteen clones with all possible combinations of the four genes were obtained and found to express the genes included. Two new combinations, pVE4-ADRC and pVE4-ARC, expressing cyt1Aa, p20 and cry4Aa, with or without cry11Aa, respectively, were more toxic than their counterparts without cyt1Aa.
Introduction
Bacillus thuringiensis subsp. israelensis (serovar H14) is a Gram-positive bacterium that forms parasporal crystal proteins (d-endotoxins) during sporulation and has been accepted as the best biocontrol agent against larvae of mosquitoes and black flies, vectors of many human infectious diseases (Margalith and Ben-Dov, 2000) . It is, however, short-lived under field conditions. One way to overcome this limitation is by using transgenic organisms expressing a combination of toxin genes (Ben-Dov et al., 1995; Wu et al., 1997; Boussiba et al., 2000) .
All six genes, encoding the toxic proteins (of 134, 128, 78, 72, 27 and 29 kDa in size) cry4Aa, cry4Ba, cry10Aa, cry11Aa, cyt1Aa and cyt2Ba, reside on a 137 kb plasmid (pBtoxis) (Ben-Dov et al., 1996; 1999) . The presence of a chaperone-like P20 [20 kDa protein encoded by the third gene of the cry11Aa operon (Dervyn et al., 1995) ] raises the levels of Cyt1Aa, Cry11Aa and Cry4Aa in E. coli (Adams et al., 1989; Visick and Whiteley, 1991; Yoshisue et al., 1992; Manasherob et al., 2001) and in an acrystalliferous strain of B. thuringiensis (Chang et al., 1992; Wu and Federici, 1993) . Transgenic bacteria are killed by expressing Cyt1Aa but are protected by coexpression with P20 (Douek et al., 1992; Wu and Federici, 1993; Manasherob et al., 2001) .
The d-endotoxin proteins differ, qualitatively and quantitatively, in their toxicity levels and against different species of mosquitoes Margalith and Ben-Dov, 2000) . Cry4Aa, Cry4Ba and Cry11Aa are much more toxic than Cyt1Aa (Delecluse et al., 1991; Margalith and Ben-Dov, 2000) , but this does not explain the high larvicidal activity of the crystal. All combinations of these four major proteins against three mosquito species display different synergy factors of between 2.5 and 15 (Crickmore et al., 1995; Poncet et al., 1995) . Cyt1Aa is least toxic of the four but is most synergistic to any of the other three and their combinations (Wu and Chang, 1985; Tabashnik, 1992; Wu et al., 1994; Crickmore et al., 1995; Yu et al., 2001) . Cyt1Aa demonstrate synergism with heterologous mosquitocidal toxins as well. Its mixture with the binary toxin of Bacillus sphaericus was highly toxic against a strain of Culex quinquefasciatus resistant to the latter (Wirth et al., 2000a) . This same mixture also extended the susceptibility range to Aedes aegypti, a species that is not normally susceptible to B. sphaericus (Wirth et al., 2000b) . Partial susceptibility of resistant mosquito strains to the B. sphaericus binary toxin was achieved by coexpressing it with Cyt1Ab from B. thuringiensis subsp. medellin in B. sphaericus (Thiery et al., 1998) or with Cyt1Aa in the acrystalliferous strain of B. thuringiensis subsp. israelensis (Li et al., 2000) .
Strains of C. quinquefasciatus resistant to single or multiple Cry4Aa, Cry4Ba and Cry11Aa toxins of B. thuringiensis subsp. israelensis retained their original sensitivity levels in the presence of moderate concentrations of Cyt1Aa . In addition, these resistant C. quinquefasciatus showed cross-resistance to Cry11Ba from B. thuringiensis subsp. jegathesan; Cyt1Aa combined with Cry11Ba can suppress most of the cross-resistance to Cry11Ba (Wirth et al., 1998) . Cyt1Aa is toxic to the Cottonwood Leaf beetle, Chrysomela scripta, and suppressed high levels of resistance to Cry3Aa found in B. thuringiensis subsp. tenebrionis (Federici and Bauer, 1998 ). All the above findings suggest that the Cyt1Aa may play a critical role in suppressing resistance to the Cry toxins and may be useful in managing resistance to bacterial insecticides (Cheong and Gill, 1997; Georghiou and Wirth, 1997; Federici and Bauer, 1998; Wirth et al., 1998; 2000a; 2000b) .
Here, cyt1Aa and p20 of B. thuringiensis subsp. israelensis were added into previously constructed pHE4 clones bearing cry4Aa and cry11Aa (Ben-Dov et al., 1995) in E. coli. From all 15 possible combinations of the four genes, the clones pVE4-ADRC (expressing cry4Aa, cry11Aa, p20 and cyt1Aa) and pVE4-ARC (cry4Aa, p20 and cyt1Aa) were most highly toxic against larvae of A. aegypti. The expressed proteins apparently interact synergistically, thereby increasing mosquito larvicidal activity significantly and decreasing lethal time in standard bioassay compared with clones that did not harbour cyt1Aa.
Results and discussion

A full series of expression vectors
To complete the set of all 15 possible combinations obtainable from four genes (cyt1Aa, p20, cry4Aa and cry11Aa), the last six were constructed by adding cyt1Aa and cyt1Aa 1 p20 (Fig. 1) to the previously described expression vectors (Ben-Dov et al., 1995) . These, and an additional clone, pVRE4-DRC (in which cyt1Aa was added in tandem as the third gene of the operon), are displayed in Table 1 . Expression of the cloned genes in all 16 recombinants was confirmed (Fig. 2) , and toxicities and synergysm among the expressed proteins quantitated (Table 1) .
Expression in the recombinants and their mosquito larvicidal activities
All four proteins were visualized by Western blots using Fig. 1 . Cloning of cyt1Aa with and without p20 into the expression vectors pHE4-A, pHE4-D and pHE4-AD harbouring cry4Aa and cry11Aa. P/O indicate early T7 promoter P A1 , which utilizes the usual E. coli RNA polymerase and two tandem lacO operators.
antibodies, either against whole d-endotoxin of B. thuringiensis subsp. israelensis ( Fig. 2A and B ; to detect Cry4Aa, Cry11Aa and Cyt1Aa) or against P20 (Fig. 2C) .
Toxicity of recombinant Bacillus spp. expressing dendotoxin genes from B. thuringiensis subsp. israelensis Ward and Ellar, 1988; Chang et al., 1993; Wu and Federici, 1993 ) is usually higher than of recombinant E. coli (Donovan et al., 1988; Adams et al., 1989; Visick and Whiteley, 1991; Chang et al., 1992; Douek et al., 1992) because of weak promotion, low stability and proteolytic cleavage of polypeptides and malformation of crystals (for an extensive review, see Margalith and Ben-Dov, 2000) . Consistently, our E. coli clones expressing all seven combinations of cry11Aa, cyt1Aa and p20 (excluding pVRE4-DRC) displayed very low toxicities, if at all (even at 5 Â 10 8 cells ml
21
, Table 1 ), even though they do express the respective proteins (Fig. 2) . The additional clone pVRE4-DRC expressing the same three genes as pVE4-DRC, which produces a lower level of Cyt1Aa but a higher level of Cry11Aa (compare lanes 10 and 9 in Fig. 2A respectively) , is an order of magnitude more toxic (Table 1 ). These two clones were derived differently: in pVRE4-DRC, cyt1Aa was added as the third gene without an additional promoter to form a single operon, whereas in pVE4-DRC, p20 and cyt1Aa were added with the promoter P A1 to the original clone pHE4-D (Ben-Dov et al., 1995) expressing Cry11Aa from another P A1 (Fig. 1) . The difference in toxicities between the two clones is discordant with results reported by Wu et al. Table 1 . Mosquito larvicidal activities and synergy factors of transgenic E. coli strains carrying combinations of genes from B. thuringiensis subsp. Israelensis against fourth-instar A. aegypti larvae, in cis and in trans (as mixtures of pRM4-RC with pHE4-AD, -A and -D) a .
Strain (reference)
Genes cloned from 
p20 and cyt1Aa ND ND ± ± pHE4-AD 1 pRM4-RC cry4Aa, cry11Aa 1 p20, cyt1Aa a. Genes in pHE4-, pRM4-and pVRE4-DRC are expressed under a single early T7 promoter (P A1 ). In the pVE4-series, cry4Aa or cry11Aa, and cyt1Aa (with or without p20) are expressed under two P A1 , respectively. LC 50 and LC 90 values represent the average numbers (cells ml
21
) of three bioassays. Numbers in parentheses are 95% confidence limits, as determined by probit analysis. b. Theoretical values of LC 50 were calculated using Tabashnik's equation (Tabashnik, 1992) assuming that pRM4-RC, pHE4-R and pRM4-C are not toxic. c. Synergy Factor contributed by expression of Cyt1Aa. d. ND, no toxicity detected, even at a concentration of 5 Â 10 8 cells ml 21 .
(1994), in which toxicity was the same when first instar A. aegypti larvae have been fed in vitro with various ratios of Cry11Aa and Cyt1Aa. This discrepancy may be explained by different susceptibilities of different instars to toxin composition. Lower sensitivities (three to eightfold) were also observed here for fourth instar larvae (Table 1) than previously for third instars (Table 2 in Ben-Dov et al., 1995) to four clones expressing cry4Aa, cry11Aa and p20 (pHE4-A, -AR, -AD and -ADR). Among the six new clones expressing cyt1Aa constructed in this study (Fig. 1) , levels of Cry4Aa and Cry11Aa in the three clones with p20 as well, pVE4-ARC, -DRC and -ADRC ( All eight clones expressing Cry4Aa ( Fig. 2A and B) displayed various levels of toxicity (Table 1) . Highest levels were achieved in pVE4-ADRC and pVE4-ARC producing Cry4Aa 1 Cyt1Aa 1 P20, with and without Cry11Aa, respectively (LC 50 of less than 1 Â 10 6 cells ml 21 ; Table 1 ), consistent with the amounts of expressed proteins (lanes 5 in both Fig. 2A and B) . The same constructs lacking p20 (pVE4-ADC and pVE4-AC) were about twofold less toxic, most likely because cells expressing Cyt1Aa lose viability (Douek et al., 1992) unless coexpressed with P20 (Manasherob et al., 2001) . Indeed, the four clones with cyt1Aa but not p20 (pRM4-C, pVE4-AC, pVE4-ADC and pVE4-DC) quickly lose colonyforming abilities, at rates that seem to be negatively correlated with toxicities (data not shown). This series of bioassays demonstrates the significance of Cyt1Aa contribution to toxicity of B. thuringiensis subsp. israelensis against A. aegypti larvae, and the importance of P20 for best results in transgenic E. coli. To substantiate this conclusion, pRM4-RC expressing P20 and Cyt1Aa was mixed with the clones expressing Cry4Aa, Cry11Aa or both (pHE4-A, -D and -AD respectively) in a 1:1 ratio by cell number (Table 1 ). This test in trans indeed yielded increased toxicities (decreased LC 50 s). Three new clones with both p20 and cyt1Aa (pVE4-ARC, -DRC and -ADRC) produced higher levels of P20 (Fig. 2C , lanes 5, 3 and 8 respectively) than previously constructed (Ben-Dov et al., 1995) P20-expressing clones pHE4-AR, -DR and -ADR (lanes 6, 4 and 7 respectively). This may be as a result of at least one of the following differences. First, p20 is immediately downstream of the promoter (P A1 ) here (Fig. 1) , whereas it is the last gene there. Second, a stretch of 245 bp separates the stop codon of the preceding cry gene and the start codon of p20 in pHE4-AR, -DR and -ADR. The same spacer stretch separates p20 from P A1 in clone pHE4-R (containing p20 alone) hence it also produces a low level of P20 (Fig. 2C,  lane 10 ). In addition, the genes in pHE4-R, pHE4-DR and pVRE4-DRC were expressed (lanes 10, 4 and 2 respectively) using their own ribosomal binding sites (RBS) rather than the T5 RBS existing in the clones harbouring cry4Aa (Ben-Dov et al., 1995) . The interpretation that the 245 bp spacer and missing T5-RBS cause reduced expression of p20 is supported by the high level of P20 in the RBS-containing clones pRM4-RC (lane 9 in Fig. 2C ; also see Manasherob et al., 2001) , pVE4-DRC, -ARC and -ADRC (lanes 3, 5 and 8 respectively).
Presence of p20 seems not to affect the expression Fig. 2B ) with pRM4-C (lane 6)]. This difference is distinct when the total protein loaded on the gel for blotting was diluted (see Fig. 8 in Manasherob et al., 2001 ). The dose±response curves (Fig. 3) of the most toxic clones (pVE4-ADRC and pVE4-ARC) were substantially steeper than of their counterparts without cyt1Aa (pHE4-ADR and pHE4-AR respectively). This observation is concordant with previous in vitro results comparing the dose±response curves of Cyt1Aa to those of the other Cry toxins (Crickmore et al., 1995) , as well as when Cyt1Aa has been added to B. sphericus toxins against A. aegypti larvae (Wirth et al., 2000b ). This phenomenon may indicate different mechanisms of pore formation between these toxins. It is consistent with the observation that LT 50 values of Cyt1Aa-expressing clones were significantly shorter than of their counterparts without cyt1Aa (Table 2 ) and reflects this enhanced toxicity. For example, at 3 Â 10 7 cells ml 21 , pVE4-ARC and pVE4-ADRC killed 32 and eight times quicker than the respective clones without cyt1Aa (pHE4-AR and pHE4-ADR) ( Table 2) . At the same cell concentration, the two cyt1Aa-expressing clones killed 100% of exposed larvae in 2 h, whereas mortalities with pHE4-AR and pHE4-ADR were about 60% and 90% only in 24 h respectively (data not shown). The differences between clones declined with decreased cell concentration used ( Table 2 ). The same was true when pVE4-DRC and pVRE4-DRC were compared with pVE4-DR (data not shown). LC 50 (0.9 Â 10 6 cells ml
) of the most toxic clone, pVE4-ADRC, resembles that of the second most toxic, pVE4-ARC (1 Â 10 6 cells ml 21 ) (Table 1) , although the latter kills 30% faster at high cell concentrations (Table 2) . This seems to be caused by a higher level of Cyt1Aa expressed in this clone ( Fig. 2A , lane 5) than in the former (Fig. 2B, lane 5) . This is consistent with the observation (Crickmore et al., 1995) , that the concentration of Cyt1Aa required to kill 98% of exposed A. aegypti larvae is lower than of Cry4Aa or of Cry11Aa. Toxicities of the two clones expressing Cry4Aa without Cry11Aa or Cyt1Aa (pHE4-A and pHE4-AR) were least toxic among the eight best (Table 1) . They were still much better than clones expressing Cry4Aa derived by others Ward and Ellar, 1988; Yoshida et al., 1989) . It is noteworthy here, that cry4Ba had been efficiently expressed in E. coli and formed phase-bright insoluble inclusions that were highly toxic to A. aegypti larvae (Angsuthanasombat et al., 1987; Chungiatupornchai et al., 1988; Delecluse et al., 1988; Ward and Ellar, 1988) . Addition of cry4Ba to our most toxic clones is thus anticipated to yield a still better mosquito control agent despite the lower synergism it displays with Cry11Aa or with Cyt1Aa (Crickmore et al., 1995) . A construct expressing all four major toxins would result in an E. coli strain with toxicity approaching that of the original B. thuringiensis subsp. israelensis; LC 90 of the latter (1.3 Â 10 4 spores ml
) against second instar larvae of A. aegypti (Silapanuntakul et al., 1983 ) is only about 200-fold lower than of our best clones against 4th instars (2.2 Â 10 6 cells ml 21 ; Table 1 ).
Synergism
The data presented here demonstrates that three out of the major d-endotoxins of B. thuringiensis subsp. israelensis (Cyt1Aa, Cry4Aa and Cry11Aa) interact synergistically to kill fourth-instar A. aegypti larvae when expressed in E. coli (Table 1) , as they do in vitro (Wu and Chang, 1985; Wu et al., 1994; Crickmore et al., 1995; Poncet et al., 1995; . Of the seven constructs harbouring cry4Aa or cry11Aa and cyt1Aa (with or without p20), all but one (pVE4-DC) displayed varying synergy factors (SF values, defined in Experimental procedures, between 1.5 and 34; Table 1 ), demonstrating that Cyt1Aa synergizes the two Cry proteins. Highest SF values (26 and 34) were displayed by two clones (pVE4-ARC and pVRE4±DRC respectively) with combinations including either of the two Crys with Cyt1Aa 1 P20.
Two clones among those derived in this study were found most suitable for mosquito biocontrol: pVE4-ARC, with LC 50 of about 10 6 cells ml 21 and SF of 26; and pVE4-ADRC, with LC 50 of about 0.9 Â 10 6 cells ml 21 and SF value of about 3. Expression in the latter of an additional toxin, Cry11Aa, is an exceedingly important asset to reduce the chance to develop resistance in the target organism, A. aegypti. Inclusion of cyt1Aa in both clones assures such an advantage Wirth et al., , 1998 2000a; 2000b) . As with toxicity, mixing clone pRM4-RC (expressing Cyt1Aa and P20) with each of the three clones expressing Cry4Aa, Cry11Aa or both (pHE4-A, -D and -AD respectively) in a 1:1 ratio by cell number also resulted in synergy between Cyt1Aa and the Crys, albeit with lower SF values (of 2.6-to 6.7-fold) than in pVE4-ADRC, -ARC and ±DRC (Table 1) , when these proteins were supplied in cis. The discrepancy in two of the three comparisons is yet to be resolved.
The two Cry proteins (24Aa and 211Aa) synergized each other as well: SF values of clones pHE4-ADR and pHE4-AD (with and without p20) were calculated from the data of Table 1 to range between 6 and 18.
Values of SF gleaned from the literature for purified toxins or lyophilized powders of B. thuringiensis strains expressing the same genes (Wu and Chang, 1985; Wu et al., 1994; Crickmore et al., 1995; Poncet et al., 1995; are similar to those obtained here in vivo (Table 1) . In most cases, combinations with cyt1Aa are most synergistic. For in vivo studies with species (such as E. coli) to which Cyt1Aa is toxic (Douek et al., 1992) , cells expressing Cyt1Aa must express P20 as well to remain alive (Manasherob et al., 2001) .
The combinations of cry4Aa 1 cry11Aa, with and without p20, have previously been cloned through E. coli (Ben-Dov et al., 1995) in the nitrogen-fixing filamentous cyanobacterium Anabaena PCC7120 to yield a high level of toxicity (Wu et al., 1997) . Our next goal is to clone the four major d-endotoxin genes into cyanobacterial strains as an approach to overcome the low efficacy and short half-life in nature of current formulations of B. thuringiensis subsp. israelensis (Margalith and Ben-Dov, 2000) . Cyanobacteria, which proliferate near the water surface and resist different environmental conditions, may thus provide an alternative for prolonged delivery of B. thuringiensis subsp. israelensis d-endotoxin to mosquito larvae that breed in the same habitat (Boussiba et al., 2000) .
Experimental procedures
Bacterial strains and plasmids
Strain XL-Blue MRF
H of E. coli (Stratagene, La Jolla, CA) was used as a host. Plasmids pRM4-RC and pRM4-C Mosquito-larvicidal E. coli-expressing d-endotoxin genes 803 (Manasherob et al., 2001) served for isolating cyt1Aa with and without p20 respectively. Plasmids pHE4-A, pHE4-AR, pHE4-D, pHE4-DR, pHE4-AD, pHE4-ADR and pHE4-R (Ben-Dov et al., 1995) served for cloning all 15 combinations of four B. thuringiensis subsp. israelensis genes (Table 1) .
Recombinant DNA methods DNA modification and restriction enzymes were used as recommended by the suppliers, and carried out as described by Sambrook and Russell (2001) . Competent cells were prepared and plasmids isolated by standard procedures. Transformants of E. coli strains XL-Blue MRF H were selected on Luria±Bertani (LB) plates containing ampicillin (100 mg ml 21 ) and tetracycline (10 mg ml 21 ). DNA was analysed by electrophoresis on horizontal 0.7% agarose slab gels and visualized with ethidium bromide.
Polymerase chain reaction
Amplification was carried out with the high fidelity Vent DNA polymerase (New England Biolabs) with 3 H -to-5 H proofreading exonuclease activity, in a DNA MiniCycler (MJ Research, Watertown, MA) for a 30-reaction cycle each. Cycle parameters consisted of 40 s at 948C, 30 s at 628C and 1±2 min at 728C.
The two primers employed to obtain p20 with cyt1Aa and cyt1Aa alone were: (i) a 26-mer 5
H -TAGGCGTATCTA-GAGGCCCTTTCGTC-3 H , with a XbaI restriction site (boldfaced); and (ii) a 26-mer 5
H -TCACCGTCATCACC-GAAACGCGCGAG-3 H , which annealed five bases downstream from the original unique site of XbaI on pRM4-RC and pRM4-C.
Cloning of cyt1Aa with and without p20 cyt1Aa and p20-cyt1Aa, each under early T7 promoter P A1 , which utilizes the usual E. coli RNA polymerase (Deuschle et al., 1986) , were amplified from pRM4-C and pRM4-RC (Manasherob et al., 2001) . Respective amplicons were digested by XbaI and inserted into pHE4-A, pHE4-D and pHE4-AD (harbouring cry4Aa, cry11Aa and both, respectively, under P A1 (Ben-Dov et al., 1995) to yield clones pVE4-AC, pVE4-ARC, pVE4-DC, pVE4-DRC, pVE4-ADC and pVE4-ADRC ( Fig. 1 and Table 1 ).
In addition to construct pVRE4-DRC (Table 1) , cyt1Aa was removed from pRM4-C by HindIII±XbaI and inserted into the same sites of pHE4-DR downstream cry11Aa and p20 under a single P A1 .
Protein analysis
Transgenic E. coli cells were grown at 378C in LB broth supplemented with 100 mg ml 21 ampicillin and induced by Isopropyl-b-D-thiogalactopyranoside (IPTG; 0.5 mM) when the culture reached an optical density at 660 nm of 0.2±0.3 (<2 Â 10 8 cells ml 21 ). Cells were harvested by centrifugation 4 h later, resuspended in distilled water at a 50-fold concentration, and disrupted by ultrasonic disintegration until complete lysis. Protein concentrations were determined by Bio-Rad protein kit; BSA was used as the standard. The aliquots were boiled (10 min) in sample treatment buffer (62.5 mM Tris-Cl, 2% SDS, 10% glycerol, 0.01% Bromophenol blue and 0.1 M DTT). Total proteins (<45 mg per lane) were separated by sodium dodecyl sulphate polyacrylamide (10±15%) gel electrophoresis (SDS±PAGE) then stained with Coomassie blue.
For immunoblot analysis, proteins were electrotransferred from the gel onto nitrocellulose filters by 2051 Midget Multiblot Electrophoretic Transfer Unit apparatus (Hoefer Scientific Instruments, San-Francisco, CA). The blots were exposed to specific antiserum directed against whole B. thuringiensis subsp. israelensis crystal (kindly provided by Armelle Delecluse, Pasteur Institute) or P20 (kindly provided by David Ellar, University of Cambridge). Protein A-alkaline phosphatase conjugate was used as a primary antibody detector. Being chromogenic substrates for alkaline phosphatase, fast nitroblue tetrazolium-5-bromo-4-chloro-3-indolylphosphate tablets (Sigma Chemical Co) were used to visualize the antigen.
Bioassays for mosquito larvicidal activity
The recombinant E. coli were grown at 378C in LB broth supplemented with 100 mg ml 21 ampicillin to optical density at 660 nm of 0.2±0.3 (<2 Â 10 8 cells ml 21 ) and induced by IPTG (0.5 mM). Cells were harvested by centrifugation after 4 h of induction, and resuspended in distilled water. Samples were added to 20 early fourth-instar A. aegypti larvae in disposable cups with 100 ml sterile tap water, and larvicidal activity was determined after 24 h at 288C (Ben-Dov et al., 1995) . Experimental LC 50 and LC 90 (concentrations of cells that kill 50% and 90% of the exposed populations respectively) were determined by using probit analysis (EPA Probit analysis programme) in at least six doses. When mixtures of two clones (after 4 h induction) were bioassays, 1:1 ratios of cell numbers were applied.
LT 50 (time taken to kill 50% of exposed larvae) was determined by following the kinetics of larval mortality using probit analysis in at least six doses.
All bioassays were performed at least three times in duplicates for each concentration.
Synergism
Synergistic interactions between Cyt1Aa and Crys were evaluated by the ratios between the theoretical LC 50 and the observed LC 50 , the so-called synergy factor (SF). The theoretical value was obtained by adapting Tabashnik's equation (Tabashnik, 1992) where LC 50 (mrc) is for the`mixture of recombinant clones' expressing different toxins; r a and r b are the relative proportions, by cell numbers, of the two clones (here, always 1:1); LC 50 (a) and LC 50 (b) are the independent LC 50 values for each recombinant clone expressing the respective toxin(s). The interactive effects between pairs of clones expressing different toxins were estimated using mixtures containing 1:1 ratios by cell number. When two proteins were expressed in one clone, their accumulation was assumed to be equal by weight.
To characterize the interaction among three toxins when Cry4Aa, Cry11Aa expressed in one clone and Cyt1Aa in another, or three of them expressed in same clone, the assumption was that Cry4Aa, Cry11Aa (r 4A111A ) to Cyt1Aa (r Cyt ) ratio is 1:1 in each case.
